Zimmer Biomet – Product Safety & Quality (2017) — Issue Type =
Outcome: Successfully withdrawn following company commitment to establish explicit Board Committee responsibility for oversight of product safety and quality. This oversight responsibility will be added to the Charter of the existing Research, Innovation and Technology Committee of the Board. This existing standing Committee will be re-named to incorporate the word “Quality”. The Board also agreed to prioritize product safety and quality and to bolster public disclosures related to product safety and quality in its forthcoming Annual Report on Form 10-K and Proxy Statement.

Board Diversity Policy – Zimmer Holdings (2013) — Issue Type =
Outcome: Successfully withdrawn following a commitment from the company to amend their governance documents to include a clear definition of diversity, inclusive of gender and race, and make diversity an intentional part of board nominee search criteria.